GBUK Global

Globally Enhancing Patient Care

A&M Capital Europe Announces Majority Investment in GBUK Group

A&M Capital Europe Announces Majority Investment in GBUK Group 344 344

A&M Capital Europe Announces Majority Investment in GBUK Group

January 9, 2024 – A&M Capital Europe (“AMCE”), a London-based middle-market private equity investment firm with €650 million of assets under management, announces the acquisition of a majority stake in GBUK Group (the “Company”), a leading global provider of specialist single-use medical devices, from H2 Equity Partners (“H2EP”).

Headquartered in the United Kingdom, GBUK designs, develops and distributes a comprehensive portfolio of own and third-party branded acute-setting medical devices across enteral feeding, vascular access, patient handling and the broader critical care environment. The Company is a top 20 supplier to the UK National Health Service (“NHS”) and supports healthcare professionals and patients in over 45 countries with more than 600,000 medical devices daily. GBUK has demonstrated a track record of penetrating new care areas by leveraging its R&D capabilities and a high-touch sales model hinging on wrap-around services.

The partnership with AMCE is expected to enable GBUK to enhance patient care further and drive the innovation required to support the evolving needs of patients and healthcare providers. Leveraging GBUK’s intimate understanding of patient needs, new product development expertise and global supply-chain capabilities, the Company is well-positioned to continue delivering on this mission and support patients globally.

Additionally, with AMCE’s support, GBUK intends to pursue bolt-on acquisitions, focusing primarily on proprietary medical device specialists in the United Kingdom and broader European and North American markets.

GBUK will continue under the leadership of its existing management team, led by CEO Mike Geering, with Mike and his team investing alongside AMCE.

AMCE was advised by Weil, Gotshal & Manges as legal adviser, Houlihan Lokey as financial adviser, MDW Capital Partners as debt adviser, Boston Consulting Group as commercial adviser, Alvarez & Marsal as accounting and operational adviser, and EY as tax adviser.

About A&M Capital Europe

AMCE is a London-headquartered, middle-market private equity investment firm specialising in building pan-European platform companies through buy-and-build in the middle market. AMCE Fund I currently has €650 million of assets under management, and GBUK represents AMCE’s seventeenth transaction. More broadly, AMCE is part of A&M Capital, a multi-strategy private equity investment firm with ~€4.8 billion in assets under management across four investment strategies. In addition, A&M Capital maintains a strategic association with Alvarez & Marsal, one of the world’s largest operationally focused advisory firms. For additional information, please visit A&M Capital Europe’s website at

GBUK Global Icon

We’re incredibly excited to announce the launch of our new International Division…

We’re incredibly excited to announce the launch of our new International Division… 344 345

We’re incredibly excited to announce the launch of our new International Division…

GBUK Global Logo

Who is GBUK Global?

GBUK Global partners internationally with ambitious companies that share our passion for Enhancing Patient Care within Enteral Feeding, Surgical & Critical Care, Vascular Access and Patient Handling.
With our market leading medical devices, along with our patient and end user solution focused philosophy, we can provide our customers and distribution partners with an industry leading go‑to market strategy, helping to enable their ambitions for future growth and success for years to come.

How will this change affect our customers and distribution partners?

Short answer: it won’t!

There won’t be any change to the high standard of communication from the team, or the quality of our products. Customers and distribution partners will still place orders the same way they always have.

At GBUK Global we value your feedback

We are committed to providing you with the best possible experience. If you have any questions, comments, or concerns, please do not hesitate to contact us.

Our customer service team is available to assist you with any inquiries you may have. You can reach us via phone, email, or by filling out the contact form. We appreciate your business and look forward to hearing from you!

Call us

+44 (0)1757 288 587
Lines open
8:30 am to 5:30 pm
Monday - Friday


For all deliveries and collections, please park in the designated bay (HGV6) and call our number to confirm that you are in the HGV bay.

Visit us

GBUK Group Ltd.
Woodland House,
Blackwood Hall Business Park,
North Duffield,
North Yorkshire,
YO8 5DD,
United Kingdom

Get in touch!


    Pain Management

    Pain Management 2080 1936

    Strategies for Coping with Chronic Pain

    Pain is a common experience that can be caused by a variety of factors, including injury, illness, or chronic conditions. read more

    Maggie Williams Award

    Maggie Williams Award Winner

    Maggie Williams Award Winner 1500 1335


    THE NOMINATION Lee has been involved in patient handling for 15 years and is one of the most enthusiastic people one could meet within the sector. He comes up with innovative products to make life easier for staff and enhance the quality of care that we can provide patients. He was recently involved in designing a product for a woman who couldn’t be moved and handled and was in a lot of pain when others were trying to move her. He truly cares about patient care and improving the standards that we set. He drove seven hours to assist moving a 63 stone man. He is well known within most health trusts in the UK for his enthusiasm and commitment to making patient care better and won’t stop until he can achieve this. With every product that he designs. it is always with the intention of making things better. He listens to the problem and comes up with a solution. There is no-one more deserving of this award and he has dedicated his career to making care better.


    GBUK Group is excited to announce the acquisition of Bluebox Medical

    GBUK Group is excited to announce the acquisition of Bluebox Medical 600 600

    GBUK Group is excited to announce the acquisition of Bluebox Medical, a UK based medical device distribution company.

    The strong portfolio of products including Grip-Lok® Fixation Devices, AutoFuser® Patient Controlled Analgesia range and InfuseIT Pressure Infusion Bags, compliment the existing GBUK offering to the NHS, and will be proudly supported by the business going forward and by our specialist sales team in the Healthcare and Enteral divisions.


    Vascular Access eLearning is now RCN accredited

    Vascular Access eLearning is now RCN accredited 600 600

    GBUK Healthcare are delighted to receive accreditation from The Royal College of Nursing for our IV E-Learning module. The RCN Accreditation is the seal of approval for healthcare training, with all accredited programmes subjected to a rigorous quality assessment ensuring they meet the RCN’s standard of excellence.


    CV Vaccination Syringes & Needles

    CV Vaccination Syringes & Needles 450 454

    GBUK Group are very proud to have provided syringes & needles to the NHS to be used as the delivery system for the CV-19 vaccine. Our team of experts are here to offer any support required to clinicians around the country. Please contact us for any support you require.

    GBUK Group has collaborated with a long-term manufacturing partner to prepare these devices for the Global market, who have made and supplied millions of products to us in the past.

    For any enquiries regarding these products please contact

    Queens Award

    GBUK Banana wins Queen’s Award for Enterprise

    GBUK Banana wins Queen’s Award for Enterprise 1500 1335

    Although its name may indicate otherwise, GBUK Banana, a division of GBUK Group, has nothing to do with bananas at all. A ‘Banana Board’ is used world-wide to allow wheelchair users to move from one position to another, for example a wheelchair to a car. The Banana Team, in collaboration with Diane Hindson from County Durham & Darlington NHS Foundation Trust, has developed a system in ‘Versal’ which undoubtedly provides a fruitful solution for improving safety in patient movement and handling – and has also won a Queen’s Award for Innovation.

    Moving a patient is a daily requirement in healthcare. Most, if not all the effort required to move the patient comes from the carers, with patients having little or limited ability to assist them.

    GBUK Banana’s Versal system helps reduce the hidden costs of pressure ulcers and musculoskeletal injury. Pressure ulcers can be life-threatening to patients, while leading to several disabilities and infections, as well as extended hospital stays. The NHS spends an estimated £1.3b annually on hospital-acquired pressure ulcers, moreover litigation costs in the NHS reached over £1b last year – reducing pressure ulcers by just 1% would help save over £13m.

    During a typical day, medical staff transfer and reposition around ten to twenty patients from bed or trolley to another bed. According to the Health and Safety Executive, the maximum recommended weight for this manouvere is 16kg for women and 25kg for men. However, patients typically weigh in excess of 55kg, which is above the weight that would be considered safe. Therefore, lifting and transferring patients increases the risk of back injury among carers.

    GBUK Banana’s Versal system helps reduce the user’s risk of error and protects both the patient and staff from injury. The technology improves patient safety by ensuring that all bony prominences of the patient are protected by two layers of slide sheet. This increases patient comfort, reduces nursing time and supports efficiency of care. Another advantage of the system is that just one design of slide sheet can be used in every clinical situation. This reduces strain on the career, simplifies training requirements and helps ensure universal compliance by its multi-purpose use.

    The effectiveness of the Versal technology was shown in one of the case studies. After a year of using the Versal system, County Durham and Darlington NHS Foundation Trust reported a 29% reduction in pressure ulcers, as well as improvement of care and nursing time as a result of the simplicity of the device.

    The GBUK Group currently supplies every NHS trust in the UK and GBUK Banana also offers a solution for home and community care providers with its On-Bed Repositioning Kit making caring safer and easier.

    GBUK Banana now sells in total £2m of single patient use slide sheets in the UK alone (including Versal), with a market share of just over 50%, making the company the market leaders in this field. Versal has been a key innovation for GBUK Banana, and has taken considerable investment in time and resources for the organisation.

    Mark Thompson, CEO of GBUK Group, said: “This award is the culmination of many years of hard work by the GBUK team. “The Queen’s Award is an internationally recognised accolade, and it an honour for us to be selected by Her Majesty The Queen in the Innovation Category. The award also gives me a chance to thank the whole of our exceptional team – who have been pivotal in improving patient care by bringing our leading technology to market.”